IL1B and atherosclerosis: The deletion of IL-1β led to a 33% reduction in total atherosclerotic lesions in high-fat diet (HFD)-fed apolipoprotein E deficient (apoE−/−) mice, demonstrating the effectiveness of anti-inflammatory treatment in improving atherosclerosis [4].